Funding opportunities
713 live opportunities from Grants.gov, NIH, NSF, and more.
Biology & Life Sciences× remove
- Developing next-generation mass spectrometric platforms for molecular cartography of the cellular membranesNational Institute of General Medical SciencesPAR-22-180 closes 5/31/2031up to $304,970activenih
- Immunometabolic regulation of inflammaging by nerve-associated macrophagesNational Institute on AgingPA-25-301 closes 5/31/2031up to $544,318activenih
- Fibroblast-immune cell interactions in the epigenetic control of parturition timingNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $805,497activenih
- Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.National Cancer InstitutePA-25-301 closes 5/31/2031up to $752,808activenih
- IL-15 mediated immune programming in nonhuman primates to improve vaccine efficacyNational Institute of Allergy and Infectious DiseasesPAR-23-073 closes 5/31/2031up to $189,000activenih
- Antibiotics-associated microbiota and functional changes in immune-mediated enterocolitis.National Institute of Allergy and Infectious DiseasesPA-24-182 closes 5/31/2031up to $184,030activenih
- Immune reprogramming with bioengineered scaffolds for the treatment of biofilm infectionNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $762,758activenih
- Modeling bone metastasis and tumor dormancy in prostate cancerNational Cancer InstitutePAR-25-130 closes 5/31/2031up to $820,855activenih
- Utilizing integrin-targeted PET imaging and therapeutics to predict and treat radiation-induced pulmonary fibrosisNational Cancer InstitutePAR-25-145 closes 5/31/2031up to $645,414activenih
- Acetylation modulates T cell receptor signalingNational Cancer InstitutePA-25-301 closes 5/31/2031up to $498,582activenih
- Lineage plasticity sensitizes FGFR3-mutant bladder cancer to FGFR inhibitorsNational Cancer InstitutePAR-25-129 closes 5/31/2031up to $637,473activenih
- Weak Cell Adhesion is a Prognostic Signature of Invasive CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $486,094activenih
- Regulation of neutrophil endoplasmic reticulum stress response by IRE1aNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $599,480activenih
- Structural and functional insights into mpox entry and neutralizationNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $897,277activenih
- Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $463,290activenih
- Selective loss of HLA gene products in driving unique breast cancer immunobiologyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $695,884activenih
- Integrating High Resolution Elemental Mapping with Spatial Transcriptomics to Analyze Metal Based Pathttps://apps.era.nih.gov/gmii/manage/view.era?applId=11296190#hways in Tumor Growth and SpreadNational Cancer InstitutePA-25-301 closes 5/31/2031up to $743,264activenih
- Polymicrobial Tickborne Infection Immunology in an Endemic Region of Long Island, New YorkNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $787,580activenih
- Mechanistic determination of host environmental impacts on Shigella virulenceNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $601,319activenih
- Defining the Role of Non-Clustered Protocadherins in Forebrain Circuit AssemblyNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $513,602activenih
- Neuroinflammation in Cerebral Small Vessel DiseaseNational Institute of Neurological Disorders and StrokePA-25-301 closes 5/31/2031up to $618,108activenih
- Defining Microbial and Host Pathways Driving Asymptomatic C. difficile Colonization Associated with Aging and High-Sugar DietsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $649,186activenih
- Structural and functional characterization of autoimmune antibodies against NMDARNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $929,257activenih
- Targeting disulfidptosis in cancer: mechanisms and preclinical translationNational Cancer InstitutePA-25-301 closes 5/31/2031up to $621,632activenih
- Pilot and Feasibility ProgramNational Institute of Diabetes and Digestive and Kidney DiseasesRFA-DK-25-003 closes 5/31/2031up to $195,304activenih